<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/CE248398-05F3-4E8E-8B5F-C66E4F8CDA9E"><gtr:id>CE248398-05F3-4E8E-8B5F-C66E4F8CDA9E</gtr:id><gtr:name>Science Foundation Ireland (SFI)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1BA013E7-2393-46ED-AD68-C2A95E3E9AC8"><gtr:id>1BA013E7-2393-46ED-AD68-C2A95E3E9AC8</gtr:id><gtr:name>Public Health Agency (PHA)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3F907894-B191-4CB3-BFF3-A3D85C75DFE8"><gtr:id>3F907894-B191-4CB3-BFF3-A3D85C75DFE8</gtr:id><gtr:name>Department for Employment and Learning (DEL)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/EC23DA53-CA73-4104-A3F6-2A9523484E69"><gtr:id>EC23DA53-CA73-4104-A3F6-2A9523484E69</gtr:id><gtr:name>Queen's University of Belfast</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Belfast</gtr:line4><gtr:line5>County Antrim</gtr:line5><gtr:postCode>BT7 1NN</gtr:postCode><gtr:region>Northern Ireland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/11E604AE-3915-4673-AEA6-852F7D6BFFD8"><gtr:id>11E604AE-3915-4673-AEA6-852F7D6BFFD8</gtr:id><gtr:name>Wellcome Trust</gtr:name><gtr:address><gtr:line1>183 EUSTON ROAD</gtr:line1><gtr:city>LONDON</gtr:city><gtr:postCode>NW1  2BE</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/CE248398-05F3-4E8E-8B5F-C66E4F8CDA9E"><gtr:id>CE248398-05F3-4E8E-8B5F-C66E4F8CDA9E</gtr:id><gtr:name>Science Foundation Ireland (SFI)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1BA013E7-2393-46ED-AD68-C2A95E3E9AC8"><gtr:id>1BA013E7-2393-46ED-AD68-C2A95E3E9AC8</gtr:id><gtr:name>Public Health Agency (PHA)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3F907894-B191-4CB3-BFF3-A3D85C75DFE8"><gtr:id>3F907894-B191-4CB3-BFF3-A3D85C75DFE8</gtr:id><gtr:name>Department for Employment and Learning (DEL)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/98C379BE-5412-4C64-9838-F46315C76505"><gtr:id>98C379BE-5412-4C64-9838-F46315C76505</gtr:id><gtr:name>Health Research Board (HRB)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6A51A252-1AEB-4EAC-A381-13BC92A00D9F"><gtr:id>6A51A252-1AEB-4EAC-A381-13BC92A00D9F</gtr:id><gtr:firstName>A</gtr:firstName><gtr:otherNames>Peter</gtr:otherNames><gtr:surname>Maxwell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_PC_15025"><gtr:id>11F859A3-1EDD-4313-A0AE-57CA6BE3775C</gtr:id><gtr:title>Integrative genomic, epigenetic and functional studies in diabetic kidney disease</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_PC_15025</gtr:grantReference><gtr:abstractText>Kidney disease is a common and devastating complication of diabetes, and represents a major public health problem worldwide. The inherited, genetic factors that play a role in determining who will get this complication are beginning to be discovered, creating opportunities to understand the underlying biological basis of diabetic kidney disease, which will guide the development of improved treatments and preventive measures. We will combine and integrate data from several complementary approaches (genetics, epigenetics, gene expression analysis and studies in model systems) to identify genes and biological processes that influence the development of diabetic kidney disease.</gtr:abstractText><gtr:technicalSummary>Diabetic kidney disease (DKD) is a leading cause of kidney failure and end stage renal disease, and brings a substantial burden of early mortality and accompanying health care costs. Genetic factors contribute to the risk of DKD. If we could identify these genetic factors, we could better understand the mechanisms by which DKD occurs, and thereby accelerate the development of better therapies. We established the GENIE consortium, a collaboration between Queen's University Belfast, University of Dublin, University of Helsinki, and the Broad Institute. Together, we completed the largest genetic study to date of DKD, and successfully identified the first two robust genetic risk factors for DKD. In a separately funded genetic study, we are collaborating with additional groups to extend our efforts and encompass larger samples. To better understand the underlying biology and pathophysiology of DKD, we propose to complement and build on our past and ongoing genetic studies in several critical ways. We will leverage a co-funding mechanism between Ireland, Northern Ireland and the US to carry out a multidisciplinary investigation of DKD. We will assemble and jointly analyze all available genetic data pertinent to DKD, to begin the process of discovering rarer variants with stronger effects on DKD. We will also generate DNA methylation data in kidney and blood, and in patients with and without DKD, and also expression data in samples relevant to DKD. We use a novel and powerful method to integrate the genetic, epigenetic and genomic data to generate hypotheses about the biological causes of DKD, and test these hypotheses with further genetic studies (sequencing in a large follow-up sample) and with functional studies in models of DKD. This international, multidisciplinary collaboration will build on genetic discoveries to help decipher the underlying biology and pathophysiology of DKD and thereby guide the prevention and treatment of this important disease.</gtr:technicalSummary><gtr:fund><gtr:end>2019-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2016-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>150000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Health Research Board (HRB)</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Wellcome Trust-HRB Irish Clinical Academic Training (ICAT) Programme</gtr:description><gtr:id>BB3E15B2-EC15-4D08-8CE6-4E8798528A9F</gtr:id><gtr:impact>Eight ICAT programme clinical research fellowships have been awarded in the first round of applications (2016-17) with starting date for these clinical academic trainees in July 2017</gtr:impact><gtr:outcomeId>58c077d878a922.73946417-2</gtr:outcomeId><gtr:partnerContribution>Queen's University is a full partner in the Wellcome ICAT programme which involves six universities in Ireland (Trinity College Dublin, University College Dublin, Royal College of Surgeons Ireland, NUI Galway, Queens University Belfast and University College Cork)</gtr:partnerContribution><gtr:piContribution>Wellcome Trust in combination with Health Research Board (RoI) and Public Health Agency R&amp;amp;D Division have invested in an Irish Clinical Academic Training (ICAT) Programme involving six partner universities in Ireland (QUB, UCD, RSCI, TCD, UCC and NUI Galway). I am the director of the Clinical Academic Training Programme in Northern Ireland (QUB and NIMDTA). Wellcome Trust, HRB and PHA R&amp;amp;D Division investment is more than &amp;pound;10 million over the next 5 years. Eight ICAT fellows will be recruited each year up to at least 2021. Each fellowship is for 4 years (Year 1 - clinical academic training; Years 2-4 postgraduate research for PhD). US Ireland R&amp;amp;D Partnership grants have enabled high quality genomics research projects to be completed through collaborations between QUB, UCD, Broad Institute (MIT &amp;amp; Harvard) and University of Helsinki. This high quality research underpins several projects offered within the ICAT programme in Ireland.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Science Foundation Ireland (SFI)</gtr:collaboratingOrganisation><gtr:country>Ireland, Republic of</gtr:country><gtr:description>Discovery of an integrated risk profile for chronic kidney disease and development of a clinical biomarker panel for personalising medicine (Stratified medicine for chronic kidney disease)</gtr:description><gtr:id>60EC9895-E1A5-4267-B558-F06D4FC55B72</gtr:id><gtr:impact>Grant started in August 2016 with recruitment of post-doctoral research fellow in January 2017 and postgraduate research student (commencing September 2017)</gtr:impact><gtr:outcomeId>58c083f7322df8.51167362-1</gtr:outcomeId><gtr:partnerContribution>We have used a combination of genome-wide association studies and epigenome-wide association studies to generate data for up to 20,000 individuals with kidney disease. These data were coupled with original in vitro observations in diabetic kidney disease models developed by our colleagues in UCD. This integrated data was used to secure the 5 year programme grant (SFI-DfE RoI-NI funding)</gtr:partnerContribution><gtr:piContribution>This application was founded on the original data obtained from research grants supported by the US Ireland R&amp;amp;D Partnership. There has been a long term strategic collaboration between Prof Catherine Godson (UCD) and my research group at QUB. This collaboration supported by the US Ireland R&amp;amp;D Partnership has been fundamental in generating new genomic data for diabetic kidney disease and more generally for chronic kidney disease. This data was integral to the successful application to the SFI-DfE partnership scheme.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Department for Employment and Learning (DEL)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Discovery of an integrated risk profile for chronic kidney disease and development of a clinical biomarker panel for personalising medicine (Stratified medicine for chronic kidney disease)</gtr:description><gtr:id>724C6186-57A9-494C-BAB9-4ED11ECA4CCB</gtr:id><gtr:impact>Grant started in August 2016 with recruitment of post-doctoral research fellow in January 2017 and postgraduate research student (commencing September 2017)</gtr:impact><gtr:outcomeId>58c083f7322df8.51167362-2</gtr:outcomeId><gtr:partnerContribution>We have used a combination of genome-wide association studies and epigenome-wide association studies to generate data for up to 20,000 individuals with kidney disease. These data were coupled with original in vitro observations in diabetic kidney disease models developed by our colleagues in UCD. This integrated data was used to secure the 5 year programme grant (SFI-DfE RoI-NI funding)</gtr:partnerContribution><gtr:piContribution>This application was founded on the original data obtained from research grants supported by the US Ireland R&amp;amp;D Partnership. There has been a long term strategic collaboration between Prof Catherine Godson (UCD) and my research group at QUB. This collaboration supported by the US Ireland R&amp;amp;D Partnership has been fundamental in generating new genomic data for diabetic kidney disease and more generally for chronic kidney disease. This data was integral to the successful application to the SFI-DfE partnership scheme.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Wellcome Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust-HRB Irish Clinical Academic Training (ICAT) Programme</gtr:description><gtr:id>5C54563D-5E04-4784-863C-C7B05B603D87</gtr:id><gtr:impact>Eight ICAT programme clinical research fellowships have been awarded in the first round of applications (2016-17) with starting date for these clinical academic trainees in July 2017</gtr:impact><gtr:outcomeId>58c077d878a922.73946417-1</gtr:outcomeId><gtr:partnerContribution>Queen's University is a full partner in the Wellcome ICAT programme which involves six universities in Ireland (Trinity College Dublin, University College Dublin, Royal College of Surgeons Ireland, NUI Galway, Queens University Belfast and University College Cork)</gtr:partnerContribution><gtr:piContribution>Wellcome Trust in combination with Health Research Board (RoI) and Public Health Agency R&amp;amp;D Division have invested in an Irish Clinical Academic Training (ICAT) Programme involving six partner universities in Ireland (QUB, UCD, RSCI, TCD, UCC and NUI Galway). I am the director of the Clinical Academic Training Programme in Northern Ireland (QUB and NIMDTA). Wellcome Trust, HRB and PHA R&amp;amp;D Division investment is more than &amp;pound;10 million over the next 5 years. Eight ICAT fellows will be recruited each year up to at least 2021. Each fellowship is for 4 years (Year 1 - clinical academic training; Years 2-4 postgraduate research for PhD). US Ireland R&amp;amp;D Partnership grants have enabled high quality genomics research projects to be completed through collaborations between QUB, UCD, Broad Institute (MIT &amp;amp; Harvard) and University of Helsinki. This high quality research underpins several projects offered within the ICAT programme in Ireland.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Public Health Agency (PHA)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Wellcome Trust-HRB Irish Clinical Academic Training (ICAT) Programme</gtr:description><gtr:id>ED482FD4-6DCA-4B9F-AC2C-44C3DBC48D6B</gtr:id><gtr:impact>Eight ICAT programme clinical research fellowships have been awarded in the first round of applications (2016-17) with starting date for these clinical academic trainees in July 2017</gtr:impact><gtr:outcomeId>58c077d878a922.73946417-3</gtr:outcomeId><gtr:partnerContribution>Queen's University is a full partner in the Wellcome ICAT programme which involves six universities in Ireland (Trinity College Dublin, University College Dublin, Royal College of Surgeons Ireland, NUI Galway, Queens University Belfast and University College Cork)</gtr:partnerContribution><gtr:piContribution>Wellcome Trust in combination with Health Research Board (RoI) and Public Health Agency R&amp;amp;D Division have invested in an Irish Clinical Academic Training (ICAT) Programme involving six partner universities in Ireland (QUB, UCD, RSCI, TCD, UCC and NUI Galway). I am the director of the Clinical Academic Training Programme in Northern Ireland (QUB and NIMDTA). Wellcome Trust, HRB and PHA R&amp;amp;D Division investment is more than &amp;pound;10 million over the next 5 years. Eight ICAT fellows will be recruited each year up to at least 2021. Each fellowship is for 4 years (Year 1 - clinical academic training; Years 2-4 postgraduate research for PhD). US Ireland R&amp;amp;D Partnership grants have enabled high quality genomics research projects to be completed through collaborations between QUB, UCD, Broad Institute (MIT &amp;amp; Harvard) and University of Helsinki. This high quality research underpins several projects offered within the ICAT programme in Ireland.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2016-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>149000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Northern Ireland Kidney Research Fund - Clinical Research Fellowship</gtr:description><gtr:end>2019-07-02</gtr:end><gtr:fundingOrg>Northern Ireland Kidney Research Fund</gtr:fundingOrg><gtr:id>D37F5CD4-2E20-43A3-B854-589C654C16E0</gtr:id><gtr:outcomeId>58c410e15781d4.99881715</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2017-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>5900000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>European Union Horizon 2020</gtr:description><gtr:end>2020-07-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:id>49BEF434-652B-4C38-B27E-59D1EFE28254</gtr:id><gtr:outcomeId>58c40fb30c34f3.96299156</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2015-08-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>3174AD61-C948-4F66-891B-58F01B342CC8</gtr:id><gtr:title>Development of next generation sequencing panel for UMOD and association with kidney disease.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/868566e5dcc6ace3b390fc38eb3aac18"><gtr:id>868566e5dcc6ace3b390fc38eb3aac18</gtr:id><gtr:otherNames>Bailie C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>595a09f4e8d635.39993902</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>704E2FAA-379F-470B-918C-F9A9337F29F0</gtr:id><gtr:title>Design and implementation of a custom next generation sequencing panel for selected vitamin D associated genes.</gtr:title><gtr:parentPublicationTitle>BMC research notes</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/630462706f9fee06369e04689eb52624"><gtr:id>630462706f9fee06369e04689eb52624</gtr:id><gtr:otherNames>Benson KA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1756-0500</gtr:issn><gtr:outcomeId>5a32dec0300c52.72792068</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D6D0FC8-A166-4028-9859-41105FFA0274</gtr:id><gtr:title>Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients.</gtr:title><gtr:parentPublicationTitle>BMC nephrology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7578debb273bbac811f9b899cd6cf66"><gtr:id>f7578debb273bbac811f9b899cd6cf66</gtr:id><gtr:otherNames>Vejakama P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1471-2369</gtr:issn><gtr:outcomeId>5a32debfcbca53.37242404</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A500FE3B-F910-4E1E-8AD0-BBCB4F11DB85</gtr:id><gtr:title>Retinal microvascular parameters are not associated with reduced renal function in a study of individuals with type 2 diabetes.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1578f0255e4dea71ffc3de53a6f650d2"><gtr:id>1578f0255e4dea71ffc3de53a6f650d2</gtr:id><gtr:otherNames>McKay GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>5aa6be7f97c396.93663155</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6AB7F6AF-C1D1-4767-9C04-2E955A34495C</gtr:id><gtr:title>Long- and short-term outcomes in renal allografts with deceased donors: A large recipient and donor genome-wide association study.</gtr:title><gtr:parentPublicationTitle>American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/27d136cb0b10a6c9ffc7a02a0d6f2ffb"><gtr:id>27d136cb0b10a6c9ffc7a02a0d6f2ffb</gtr:id><gtr:otherNames>Hernandez-Fuentes MP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1600-6135</gtr:issn><gtr:outcomeId>5aa6bf7f74ede1.19591663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F71EB70D-459E-4F89-97C3-A6A4BB5DBA3C</gtr:id><gtr:title>The Genetic Landscape of Renal Complications in Type 1 Diabetes.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ca30ab5eda1e7c540dec50b83c7b1835"><gtr:id>ca30ab5eda1e7c540dec50b83c7b1835</gtr:id><gtr:otherNames>Sandholm N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>58c40ade59b7b0.92730358</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A96CDDFC-919C-40EB-8068-C86A1CBD38FD</gtr:id><gtr:title>Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDLand HDL.</gtr:title><gtr:parentPublicationTitle>Journal of diabetes research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1c60a88f488ae2ec9a44bb6fb8949c2"><gtr:id>d1c60a88f488ae2ec9a44bb6fb8949c2</gtr:id><gtr:otherNames>Griffiths K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>595a0a2b548a30.20251472</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_PC_15025</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>